« Lunginnov develops innovative solutions for respiratory diseases that enable earlier therapeutic decision to be helpful for patients. »
Lunginnov markets 2 product lines:
- A range of unique reagents for research in Life Sciences
- A range of original medical devices for In Vitro Diagnostic
Scientific and Technological Innovation
Lunginnov is declared manufacturer to the french regulatory agency ANSM. The company devotes a significant part of its budget to its internal R&D and to set up collaborative projects with Research Centers in France and abroad.
Through its website www.lunginnov.eu, the brand Lunginnov are known in over 135 countries, thanks to a network that has more than 24 distributors present on 5 continents.
Lunginnov is specialized on endocan and CG-cleaved endocan as markers of lung infection/injury, by proposing specific tools of high quality researchers and clinicians.